JNJ

234.31

+0.56%↑

ISRG

478.08

-0.13%↓

ABT

108.15

-0.74%↓

RDY

13.99

+1.3%↑

NEOG

10.53

+2.53%↑

JNJ

234.31

+0.56%↑

ISRG

478.08

-0.13%↓

ABT

108.15

-0.74%↓

RDY

13.99

+1.3%↑

NEOG

10.53

+2.53%↑

JNJ

234.31

+0.56%↑

ISRG

478.08

-0.13%↓

ABT

108.15

-0.74%↓

RDY

13.99

+1.3%↑

NEOG

10.53

+2.53%↑

JNJ

234.31

+0.56%↑

ISRG

478.08

-0.13%↓

ABT

108.15

-0.74%↓

RDY

13.99

+1.3%↑

NEOG

10.53

+2.53%↑

JNJ

234.31

+0.56%↑

ISRG

478.08

-0.13%↓

ABT

108.15

-0.74%↓

RDY

13.99

+1.3%↑

NEOG

10.53

+2.53%↑

Search

ResMed Inc

Закрыт

СекторЗдравоохранение

262.42 4.55

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

251.38

Макс.

264.55

Ключевые показатели

By Trading Economics

Доход

-31M

349M

Продажи

-12M

1.3B

P/E

Средняя по отрасли

26.175

90.422

Дивидендная доходность

0.87

Рентабельность продаж

26.096

Сотрудники

10,600

EBITDA

-29M

503M

Рекомендации

By TipRanks

Рекомендации

Покупка

Прогноз на 12 месяцев

+18.02% upside

Дивиденды

By Dow Jones

Дивидендная доходность

Средняя по отрасли

0.87%

2.13%

Следующий отчет о доходах

22 апр. 2026 г.

Дата следующей выплаты дивидендов

19 мар. 2026 г.

Следующая эксдивидендная дата

12 февр. 2026 г.

Рыночная статистика

By TradingEconomics

Рыночная капитализация

-539M

37B

Предыдущая цена открытия

257.87

Предыдущая цена закрытия

262.42

Новостные настроения

By Acuity

9%

91%

8 / 352 Рейтинг в Healthcare

ResMed Inc График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

3 февр. 2026 г., 23:11 UTC

Главные движущие силы рынка
Приобретения, слияния, поглощения

Silicon Laboratories Shares Up On Report of $7 Billion Texas Instruments Acquisition Deal

3 февр. 2026 г., 23:50 UTC

Обсуждения рынка

Global Forex and Fixed Income Roundup: Market Talk

3 февр. 2026 г., 23:50 UTC

Обсуждения рынка

Nikkei May Decline After Hitting All-Time High -- Market Talk

3 февр. 2026 г., 23:42 UTC

Обсуждения рынка

Gold Edges Lower on Possible Technical Correction -- Market Talk

3 февр. 2026 г., 23:41 UTC

Приобретения, слияния, поглощения

KKR Makes AI Play With $10.9B Asia Data-Center Deal

3 февр. 2026 г., 23:38 UTC

Отчет

AMD Sales Climb on Help From Data-Center Business -- Update

3 февр. 2026 г., 23:29 UTC

Приобретения, слияния, поглощения

KKR-Consortium Deal in STT GDC Is One of the Largest Digital-Infrastructure Transactions in Southeast Asia

3 февр. 2026 г., 23:27 UTC

Приобретения, слияния, поглощения

Netflix, Warner Defend Proposed Deal in Senate Hearing -- WSJ

3 февр. 2026 г., 23:25 UTC

Приобретения, слияния, поглощения

KKR-Consortium Expects Deal to Close by Early 2H of 2026

3 февр. 2026 г., 23:23 UTC

Приобретения, слияния, поглощения

KKR Consortium With Singtel to Own 75% and 25% Stake in ST Telemedia Global Data Centres

3 февр. 2026 г., 23:22 UTC

Приобретения, слияния, поглощения

KKR-Led Consortium to Buy Singapore-Based Global Data-Center Provider Valued at S$13.8B

3 февр. 2026 г., 23:19 UTC

Обсуждения рынка

Australia Gold Miners Tipped to Rally Higher -- Market Talk

3 февр. 2026 г., 23:19 UTC

Обсуждения рынка

Global Equities Roundup: Market Talk

3 февр. 2026 г., 22:56 UTC

Главные движущие силы рынка
Приобретения, слияния, поглощения

Silicon Laboratories Shares Up On Report of $7B Texas Instruments Acquisition Deal

3 февр. 2026 г., 22:40 UTC

Отчет

Amdocs Extends Collaboration With T-Mobile

3 февр. 2026 г., 22:39 UTC

Отчет

Amdocs 1Q Adj EPS $1.81

3 февр. 2026 г., 22:39 UTC

Отчет

Amdocs 1Q Rev $1.16B

3 февр. 2026 г., 22:39 UTC

Отчет

Amdocs 1Q EPS $1.45 >

3 февр. 2026 г., 22:38 UTC

Отчет

Amdocs: Shimie Hortig to Succeed Shuky Sheffer as President and CEO, Effective March 31

3 февр. 2026 г., 22:30 UTC

Приобретения, слияния, поглощения

Bob Iger's Second Time as CEO Wasn't Great for the Stock. He Still Leaves Behind A Strong Legacy. -- Barrons.com

3 февр. 2026 г., 22:22 UTC

Приобретения, слияния, поглощения

Texas Instruments Nearing $7B Deal for Silicon Laboratories, Sources Tell FT

3 февр. 2026 г., 22:14 UTC

Отчет

AMD Expects to Scale AI Business to Tens of Billions in Annual Sales in 2027, CEO Says

3 февр. 2026 г., 22:13 UTC

Отчет

AMD Expects Data-Center Unit Sales to Jump More Than 60% a Year Over Next Three to Five Years, CEO Says

3 февр. 2026 г., 22:12 UTC

Отчет

AMD in Talks With Several Companies About At-Scale, Multi-Year Chip Deployments, CEO Says

3 февр. 2026 г., 22:10 UTC

Отчет

AMD CEO: Eight of 10 Biggest AI Companies Use Instinct Chip to Power Production Workloads

3 февр. 2026 г., 22:10 UTC

Отчет

Blackstone Stock, Alternative Managers, BDCs Dive as Software Woes Infect Private Credit -- Barrons.com

3 февр. 2026 г., 22:10 UTC

Обсуждения рынка

Key Drivers Underpinning Shaw's Bullish View of Gold Intact -- Market Talk

3 февр. 2026 г., 22:10 UTC

Отчет

AMD CEO: Enterprises Are Modernizing Data Centers to Have Compute Needed for New AI Workflows

3 февр. 2026 г., 22:09 UTC

Отчет

AMD CEO: Hyperscalers Expanding Infrastructure to Meet Growing Cloud-Services Demand in AI

3 февр. 2026 г., 22:09 UTC

Отчет

AMD CEO: Demand Accelerated Across Data Center, Gaming and PC

Сравнение c конкурентами

Изменение цены

ResMed Inc Прогноз

Целевая цена

By TipRanks

18.02% рост

Прогноз на 12 месяцев

Средняя 300.64 USD  18.02%

Максимум 345 USD

Минимум 265 USD

Основано на мнении 13 аналитиков Wall Street, спрогнозировавших целевые цены для ResMed Inc на следующие 12 месяцев – Данные за последние 3 месяца.

Консенсус по рейтингу

By TipRanks

Покупка

13 ratings

8

Покупка

5

Удержание

0

Продажа

Настроения

By Acuity

8 / 352Рейтинг в Здравоохранение

Новостные настроения

Сильные свидетельства восходящего тренда

Волатильность

Ниже среднего

Объем новостей (RCV)

Ниже среднего

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

$

О компании ResMed Inc

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; and NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry over several nights. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN's software solutions. The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
help-icon Live chat